These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36474517)

  • 41. Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children.
    Ling Y; Zhang T; Guo W; Zhu Z; Tian J; Cai C; Xu Y
    BMC Infect Dis; 2020 Jul; 20(1):534. PubMed ID: 32698769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An analysis of 20 clinical cases of refractory mycoplasma pneumonia in children.
    Zhai YY; Wu SZ; Yang Y; Yang LY; Xu JX; Huang ZH; He ZT; Lin YN; Chen DH
    Ann Palliat Med; 2020 Sep; 9(5):2592-2599. PubMed ID: 32921097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.
    Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH
    BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and validation of a simple-to-use nomogram for predicting the delayed radiographic recovery in children with mycoplasma pneumoniae pneumonia complicated with atelectasis.
    Luo Y; Dai J; Tang G; He S; Fu W
    J Investig Med; 2023 Oct; 71(7):722-729. PubMed ID: 37269107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The correlation between vitamin a status and refractory Mycoplasma Pneumoniae pneumonia (RMPP) incidence in children.
    Li Y; Guo Z; Zhang G; Tian X; Li Q; Chen D; Luo Z
    BMC Pediatr; 2020 Jul; 20(1):359. PubMed ID: 32731898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical characteristics and predictive factors of refractory Mycoplasma pneumoniae pneumonia].
    Liu JR; Peng Y; Yang HM; Li HM; Zhao SY; Jiang ZF
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):915-8. PubMed ID: 23324149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children.
    Shan LS; Liu X; Kang XY; Wang F; Han XH; Shang YX
    World J Pediatr; 2017 Aug; 13(4):321-327. PubMed ID: 28130749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increasing Age Affected Polymorphonuclear Neutrophils in Prognosis of
    Zhao Q; Zhang T; Zhu B; Bi Y; Jiang SW; Zhu Y; Zhao D; Liu F
    J Inflamm Res; 2021; 14():3933-3943. PubMed ID: 34429628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia.
    Wu X; Lu W; Wang T; Xiao A; Guo X; Xu Y; Li S; Liu X; Zeng H; He S; Zhang X
    BMC Infect Dis; 2023 Oct; 23(1):661. PubMed ID: 37798699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia.
    Ding Y; Chu C; Li Y; Li G; Lei X; Zhou W; Chen Z
    BMC Infect Dis; 2018 Aug; 18(1):439. PubMed ID: 30157804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    Dai FF; Liu FQ; Chen X; Yang J; Wang K; Guo CY
    J Clin Pharm Ther; 2021 Jun; 46(3):705-710. PubMed ID: 33403672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae.
    Komatsu H; Tsunoda T; Inui A; Sogo T; Fujisawa T
    Braz J Infect Dis; 2014; 18(3):294-9. PubMed ID: 24389284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children.
    Wang X; Zhong LJ; Chen ZM; Zhou YL; Ye B; Zhang YY
    World J Pediatr; 2018 Aug; 14(4):344-349. PubMed ID: 29948966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children.
    Tsai TA; Tsai CK; Kuo KC; Yu HR
    J Microbiol Immunol Infect; 2021 Aug; 54(4):557-565. PubMed ID: 33268306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a scale for early prediction of refractory Mycoplasma pneumoniae pneumonia in hospitalized children.
    Bi Y; Zhu Y; Ma X; Xu J; Guo Y; Huang T; Zhang S; Wang X; Zhao D; Liu F
    Sci Rep; 2021 Mar; 11(1):6595. PubMed ID: 33758243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mycoplasma pneumoniae infection prediction model for hospitalized community-acquired pneumonia children.
    Chen J; Yin Y; Zhao L; Zhang L; Zhang J; Yuan S
    Pediatr Pulmonol; 2021 Dec; 56(12):4020-4028. PubMed ID: 34547836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokines and refractory mycoplasma pneumoniae pneumonia in children: a systematic review.
    Yu M; Zhang Q; Yan H
    Minerva Pediatr (Torino); 2024 Apr; 76(2):259-267. PubMed ID: 37155205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy.
    Zhu Z; Zhang T; Guo W; Ling Y; Tian J; Xu Y
    BMC Infect Dis; 2021 Jan; 21(1):126. PubMed ID: 33509121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive
    Ha SG; Oh KJ; Ko KP; Sun YH; Ryoo E; Tchah H; Jeon IS; Kim HJ; Ahn JM; Cho HK
    J Korean Med Sci; 2018 Oct; 33(43):e268. PubMed ID: 30344461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Refractory Mycoplasma Pneumonia in Children: A Systematic Review and Meta-analysis of Laboratory Features and Predictors.
    Huang W; Xu X; Zhao W; Cheng Q
    J Immunol Res; 2022; 2022():9227838. PubMed ID: 35795531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.